RESUMEN
The corrosion of metals, i.e., the initiation and acceleration of the surface deterioration of metals through an electrochemical reaction with the surrounding intrusive environment, is a global concern because of the economic and environmental impacts. Corrosion inhibitors are considered the most practical choice among the available corrosion protection techniques due to their effectiveness in terms of functionality and cost. The use of traditional and toxic corrosion inhibitors has led to environmental issues, arousing the need for green counterparts that are environmentally friendly, easily accessible, biodegradable, and cost-effective. In this review, the utilization of green corrosion inhibitors purely acquired from renewable sources is explored, with an in-depth focus on the recent advancements in the use of fruit and vegetable extracts as green corrosion inhibitors. In particular, fruits and vegetables are natural sources of various phytochemicals that exhibit key potential in corrosion inhibition. To shed light on the true potential of such extracts in the protection of steel in acidic environments, the experimental techniques involved in corrosion inhibition and the mechanism of corrosion inhibition are discussed in detail. The study highlights the potential of fruit and vegetable extracts as non-toxic, economical, and effective corrosion inhibitors in the pursuit of green chemistry. In addition to discussing and outlining the current status and opportunities for employing fruit and vegetable extracts as corrosion inhibitors, the current review outlines the challenges involved in the utilization of such extracts in corrosion inhibition.
Asunto(s)
Frutas , Verduras , Corrosión , Extractos Vegetales , AceroRESUMEN
The edible tubers from different species of Dioscorea are a major source of food and nutrition for millions of people. Some of the species are medicinally important but others are toxic. The genus consists of about 630 species of almost wholly dioecious plants, many of them poorly characterized. The taxonomy of Dioscorea is confusing and identification of the species is generally problematic. There are no adequate anatomical studies available for most of the species. This study is aimed to fill this gap and provides a detailed investigation of the anatomy and micro-morphology of the rhizomes and tubers of five different species of Dioscorea, namely D. balcanica, D. bulbifera, D. polystachya, D. rotundata and D. villosa. The primary features that can help in distinguishing the species include the nature of periderm, presence or absence of pericyclic sclereids, lignification in the phloem, types of calcium oxalate crystals and features of starch grains. The descriptions are supported with images of bright-field and scanning electron microscopy for better understanding of these species. The diagnostic key of anatomical features included in this paper can help distinguish the investigated species unambiguously. Additionally, HPTLC analyses of authentic and commercial samples of the five species are described.
Asunto(s)
Dioscorea/anatomía & histología , Dioscorea/química , Cromatografía en Capa Delgada , Dioscorea/clasificación , Dioscorea/ultraestructura , Tubérculos de la Planta/anatomía & histología , Tubérculos de la Planta/química , Tubérculos de la Planta/clasificación , Tubérculos de la Planta/ultraestructuraRESUMEN
Salvia divinorum--a species traditionally cultivated in Oaxaca, Mexico--possesses hallucinogenic properties. It is legally recognized as a controlled substance and prohibited in many countries. The proper identification of the plant, both in fresh and dried forms, is an important issue in crime-prevention campaigns. This paper provides a thorough anatomical description of leaves, petioles, and stems of S. divinorum. Detailed investigation of foliar trichomes was performed and illustrated. In addition, chromatographic analyses, including TLC and HPLC, were applied to fresh and dried plant material, together with the standard reference salvinorin A. A comprehensive identification method for S. divinorum based on a thorough anatomical examination is proposed, combined with chemical analysis for proper plant recognition.
Asunto(s)
Diterpenos de Tipo Clerodano/análisis , Salvia/anatomía & histología , Salvia/química , Calibración , Cromatografía Líquida de Alta Presión/normas , Cromatografía en Capa Delgada/normas , México , Fitoterapia , Hojas de la Planta/anatomía & histología , Hojas de la Planta/química , Tallos de la Planta/anatomía & histología , Tallos de la Planta/química , Plantas Medicinales , Estándares de Referencia , Salvia/clasificaciónRESUMEN
Yohimbine is the major alkaloid found in the stem bark of yohimbe, Pausinystalia johimbe (Rubiaceae), an evergreen tree native to Africa. The objectives of the current study were to provide a detailed anatomy of yohimbe bark, as well as to determine the quantity of yohimbine in the raw yohimbe products sold online. Twelve commercial raw materials of yohimbe were analyzed by microscopic and ultra performance liquid chromatography-UV-MS methods. The study revealed that three samples were probably adulterated and four other samples contained various levels of impurities. Yohimbine was not detected in one sample, whereas its presence in other samples was found to be in the range 0.1-0.91%. The present work also provides a detailed anatomy of the stem bark of yohimbe, with light and scanning electron microscopy images, for proper identification and authentication.
Asunto(s)
Cromatografía Liquida/métodos , Espectrometría de Masas/métodos , Microscopía/métodos , Pausinystalia/química , Corteza de la Planta/química , Yohimbina/análisisRESUMEN
This paper presents a comparative study of anatomy of leaves, stems and roots of three species of Plumbago, namely P. auriculata Lam., P. indica L. and P. zeylanica L. by light microscopy. The paper also provides qualitative and quantitative analysis of the naphthoquinone, plumbagin-a major constituent present in these species-using UPLC-UV. Microscopic examinations revealed the presence of distinctive differences in the anatomical features of the leaf, stem and root of the three species, and these can thus be used for identification and authentication of these species. UPLC-UV analysis showed the highest concentration of plumbagin in the roots of P. zeylanica (1.62% w/w) followed by the roots of P. indica (0.97% w/w) and then P. auriculata (0.33-0.53% w/w). In contrast, plumbagin was not detected in the stems and leaves of P. indica and in the leaves of P. auriculata, whereas very low concentrations (<0.02% w/w) of plumbagin were detected in the stems and leaves of P. zeylanica and in the stems of P. auriculata. HPTLC fingerprints of the leaf and root of the three species exhibited distinguishable profiles, while those of the stems were undifferentiated.
Asunto(s)
Cromatografía Liquida/métodos , Plumbaginaceae/clasificación , Cromatografía Líquida de Alta Presión/métodos , Microscopía , Naftoquinonas/análisis , Fitoterapia , Hojas de la Planta , Raíces de Plantas , Tallos de la Planta , Plantas Medicinales , Plumbaginaceae/anatomía & histología , Plumbaginaceae/química , Espectrofotometría UltravioletaRESUMEN
The aim of this study was to investigate the antimycobacterial activity of the major daucane constituent, ferutinin (jaeschkeandiol p-hydroxybenzoate, 1), four of its natural analogues, its hydrolysis products, as well as methyl p-hydroxybenzoate (methylparaben) against Mycobacterium smegmatis, a rapidly growing surrogate of Mycobacterium tuberculosis. The agar dilution assay was utilised for an antimycobacterial evaluation of single compounds. A modified agar dilution assay, the checkerboard method, was utilised for evaluating the potentiating effect of 1 on different antitubercular drugs, namely isoniazid, ethionamide, rifampin and streptomycin. In the agar dilution assay, 1 exhibited higher potency (minimum inhibitory concentration [MIC] 10 µg mL⻹) than streptomycin and rifampin (MIC 20 µg mL⻹ for each). Of the natural analogues, 8,9-epoxyjaeschkeandiol p-hydroxybenzoate and 8,9-epoxyjaeschkeandiol benzoate exhibited marginal activity (MIC ≥ 40 and 80 µg mL⻹, respectively). The checkerboard method showed that the combination of 1 with each antitubercular drug led to mutual enhancement of the antimycobacterial activity with isoniazid and ethionamide, while no such effect was observed with rifampin or streptomycin. Based on this study and earlier studies with Staphylococcus aureus, the major constituent 1 may be responsible for the major part of the antimicrobial activity of the root of Ferula hermonis.
Asunto(s)
Antibacterianos/farmacología , Antibióticos Antituberculosos/farmacología , Benzoatos/farmacología , Cicloheptanos/farmacología , Ferula/química , Mycobacterium tuberculosis/efectos de los fármacos , Raíces de Plantas/química , Sesquiterpenos/farmacología , Compuestos Bicíclicos con Puentes/farmacología , Etionamida/farmacología , Isoniazida/farmacología , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Parabenos/farmacología , Rifampin/farmacología , Estreptomicina/farmacologíaRESUMEN
The double-edged sword of antibiotic use in the fight against disease has saved countless lives at the cost of an escalation in pathogenic bacteria with increased resistance to multiple antibiotic classes. Reduction of resistance is a complicated multi-step endeavor that requires a sustained international effort of reduced utilization, infection control and development of effective and economical antimicrobial agents. The carbapenems are beta-lactam antibiotics that are stable to most beta-lactamases. They have potent bactericidal activity against a wide range of Gram-positive and Gram-negative aerobic bacteria as well as against anaerobic bacteria, while being safe, efficacious and tolerable. The use of carbapenems in hospitals has therefore been restricted to the empirical treatment of critical patients with a variety of serious infections, e.g., nosocomial pneumonia, septicemia, meningitis and cystic fibrosis. This article reviews patents claiming carbapenem antibacterial agents published from 2004-2008.
Asunto(s)
Antibacterianos/síntesis química , Antibacterianos/uso terapéutico , Infecciones Bacterianas/tratamiento farmacológico , Carbapenémicos/síntesis química , Carbapenémicos/uso terapéutico , Animales , Antibacterianos/efectos adversos , Antibacterianos/farmacocinética , Infecciones Bacterianas/microbiología , Carbapenémicos/efectos adversos , Carbapenémicos/farmacocinética , Descubrimiento de Drogas , Farmacorresistencia Bacteriana Múltiple , Humanos , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Patentes como Asunto , Relación Estructura-Actividad , Resultado del TratamientoRESUMEN
Naturally occurring cannabinoids (phytocannabinoids) are biosynthetically related terpenophenolic compounds uniquely produced by the highly variable plant, Cannabis sativa L. Natural and synthetic cannabinoids have been extensively studied since the discovery that the psychotropic effects of cannabis are mainly due to Delta(9)-THC. However, cannabinoids exert pharmacological actions on other biological systems such as the cardiovascular, immune and endocrine systems. Most of these effects have been attributed to the ability of these compounds to interact with the cannabinoid CB1 and CB2 receptors. The FDA approval of Marinol, a product containing synthetic Delta(9)-THC (dronabinol), in 1985 for the control of nausea and vomiting in cancer patients receiving chemotherapy, and in 1992 as an appetite stimulant for AIDS patients, has further intensified the research interest in these compounds. This article reviews patents (2003-2007) that describe methods for isolation of cannabinoids from cannabis, chemical and chromatographic methods for their purification, synthesis, and potential therapeutic applications of these compounds.
Asunto(s)
Cannabinoides/síntesis química , Cannabinoides/uso terapéutico , Descubrimiento de Drogas/métodos , Psicotrópicos/uso terapéutico , Animales , Estimulantes del Apetito/farmacología , Estimulantes del Apetito/uso terapéutico , Cannabinoides/química , Cannabinoides/farmacología , Enfermedades Cardiovasculares/tratamiento farmacológico , Sistema Cardiovascular/efectos de los fármacos , Humanos , Psicotrópicos/síntesis química , Psicotrópicos/farmacología , Receptores de Cannabinoides/clasificación , Receptores de Cannabinoides/fisiología , Relación Estructura-ActividadRESUMEN
Analogs of the malaria therapeutic, artemisinin, possess in vitro and in vivo anticancer activity. In this study, two dimeric artemisinins (NSC724910 and 735847) were studied to determine their mechanism of action. Dimers were >1,000 fold more active than monomer and treatment was associated with increased reactive oxygen species (ROS) and apoptosis induction. Dimer activity was inhibited by the antioxidant L-NAC, the iron chelator desferroxamine and exogenous hemin. Similarly, induction of heme oxygenase (HMOX) with CoPPIX inhibited activity, whereas inhibition of HMOX with SnPPIX enhanced it. These results emphasize the importance of iron, heme and ROS in activity. Microarray analysis of dimer treated cells identified DNA damage, iron/heme and cysteine/methionine metabolism, antioxidant response, and endoplasmic reticulum (ER) stress as affected pathways. Detection of an ER-stress response was relevant because in malaria, artemisinin inhibits pfATP6, the plasmodium orthologue of mammalian sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPases (SERCA). A comparative study of NSC735847 with thapsigargin, a specific SERCA inhibitor and ER-stress inducer showed similar behavior in terms of transcriptomic changes, induction of endogenous SERCA and ER calcium mobilization. However, thapsigargin had little effect on ROS production, modulated different ER-stress proteins and had greater potency against purified SERCA1. Furthermore, an inactive derivative of NSC735847 that lacked the endoperoxide had identical inhibitory activity against purified SERCA1, suggesting that direct inhibition of SERCA has little inference on overall cytotoxicity. In summary, these data implicate indirect ER-stress induction as a central mechanism of artemisinin dimer activity.
Asunto(s)
Antineoplásicos/farmacología , Artemisininas/farmacología , Retículo Endoplásmico/efectos de los fármacos , Hemo-Oxigenasa 1/metabolismo , Hemo/metabolismo , Estrés Oxidativo/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Acetilcisteína/análogos & derivados , Acetilcisteína/farmacología , Antioxidantes/farmacología , Apoptosis/efectos de los fármacos , Artemisia/química , Biomarcadores/metabolismo , Western Blotting , Calcio/metabolismo , Ciclo Celular/efectos de los fármacos , Dimerización , Retículo Endoplásmico/metabolismo , Inhibidores Enzimáticos/farmacología , Perfilación de la Expresión Génica , Humanos , Lisina/análogos & derivados , Lisina/farmacología , Análisis de Secuencia por Matrices de Oligonucleótidos , ATPasas Transportadoras de Calcio del Retículo Sarcoplásmico/antagonistas & inhibidores , ATPasas Transportadoras de Calcio del Retículo Sarcoplásmico/metabolismo , Tapsigargina/farmacologíaRESUMEN
A fluorometric microplate assay was performed for the detection of respiratory burst activity in a human leukaemia cell line HL-60 by assessing oxidation of 2',7'-dichloro fluorescin diacetate (DCFH-DA). This method is based on the detection of DCFH oxidation due to the presence of hydrogen peroxide. In the present study, the antioxidant activity of a number of structurally related flavonoids of plant origin and some of their microbial transformation products (1-18) were evaluated.
Asunto(s)
Antioxidantes/farmacología , Flavonoides/farmacología , Fitoterapia , Plantas Medicinales , Estallido Respiratorio/efectos de los fármacos , Antioxidantes/administración & dosificación , Antioxidantes/uso terapéutico , Relación Dosis-Respuesta a Droga , Flavonoides/administración & dosificación , Flavonoides/uso terapéutico , Citometría de Flujo , Fluoresceínas/química , Células HL-60/efectos de los fármacos , Humanos , Oxidación-ReducciónRESUMEN
Photooxygenation of anhydrodeoxydihydroartemisinin (4) followed by chromatographic separation of the reaction mixture yielded the new compounds alpha- (5) and beta-hydroperoxydeoxyartemisitene (8) and the formate ester 7, together with two previously reported compounds, 6 and 9. Reduction of 5 using polymer-bound triphenylphosphine afforded the new compound dihydrodeoxyartemisitene (10). Treatment of 10 with a catalytic amount of BF(3)-OEt(2) yielded the C(2)-symmetrical dimer bis(dihydrodeoxyartemisitene) ether (11) and two new compounds, dihydrodeoxyartemisitene methyl ether (12) and the dimer 13, as minor products. Dehydroacetoxylation of 5 using acetic anhydride in pyridine afforded deoxyartemisitene (14). The identities of the new compounds (5, 7, 8, 10-14) were deduced from their spectral data and by chemical derivatization. The stereochemistry of dimer 11 was defined on the basis of X-ray crystallographic analysis. All compounds were evaluated in vitro in the National Cancer Institute drug-screening program consisting of 60 human cancer cell lines derived from nine different tissues. Of the compounds tested, deoxyartemisitene (14) demonstrated significant cytotoxicity against a number of human cancer cell lines.